Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System

Pyrazinamide (PZA) is a key antituberculosis drug, yet no rapid susceptibility test is commercially available. PZA drug susceptibility testing (DST) was performed directly on sputum samples from 327 patients and compared with the indirect method by using the Bactec MGIT 960 system in the context of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Microbiol
Main Authors: Demers, Anne-Marie, Venter, Amour, Friedrich, Sven O., Rojas-Ponce, Gabriel, Mapamba, Daniel, Jugheli, Levan, Sasamalo, Mohammed, Almeida, Deepak, Dorasamy, Afton, Jentsch, Ute, Gibson, Mara, Everitt, Daniel, Eisenach, Kathleen D., Diacon, Andreas H.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2016
Assuntos:
Mycobacteriology and Aerobic Actinomycetes
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4844746/
https://ncbi.nlm.nih.gov/pubmed/26912751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.03162-15
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares